Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
Personalized medicine: Mutated tumors respond to therapy Mutations in the p53 tumor suppressor gene could offer a predictive biomarker of response to certain drugs in triple-negative breast cancer. Jill Bargonetti from Hunter College in New York, USA, and colleagues showed that mutant p53, which is...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/b2c5b334b48243aca21c4d45cdb91aa3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|